Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia

Clinical trial NCT06896994 · RECRUITING

Trial details

NCT number: NCT06896994
Sponsor: Beijing Tiantan Hospital
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Postherpetic Neuralgia

Start date: 2025-04-01
Primary completion: 2026-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.